Charles River Laboratories (CRL)

NYSE HEALTHCARE
$163.84 -1.77% RSI 41 Neutral Add Alert

Moving Averages

SMA 200
$174.50
Price below

Company Profile

Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.

Sector
HEALTHCARE
Industry
DIAGNOSTICS & RESEARCH
Market Cap
$8.67B
P/E Ratio
None
EPS
$-2.92
Beta
1.616
Dividend Yield
0.00%
52-Week High
$228.88
52-Week Low
$99.8

Similar stocks in DIAGNOSTICS & RESEARCH

Data last updated: April 11, 2026 at 11:04 AM EDT

Track CRL for free

Get e-mail RSI alerts when Charles River Laboratories enters oversold or overbought territory. Free forever.

Add Alert